Protara Therapeutics: biotech net-net with low failure risk
turningroughstones.substack.com
Ticker: TARA (Nasdaq). Date research and write-up: 2023-02-12 Price around 2023-02-12: 3.3 USD. Current price: about 3.3 USD. Estimated multiple Liquidation Value/Market cap: 1.3 This is a US-based biotech company. The company was formerly known as Artara Therapeutics. On 9 January 2020 Artara Therapeutics
Protara Therapeutics: biotech net-net with low failure risk
Protara Therapeutics: biotech net-net with…
Protara Therapeutics: biotech net-net with low failure risk
Ticker: TARA (Nasdaq). Date research and write-up: 2023-02-12 Price around 2023-02-12: 3.3 USD. Current price: about 3.3 USD. Estimated multiple Liquidation Value/Market cap: 1.3 This is a US-based biotech company. The company was formerly known as Artara Therapeutics. On 9 January 2020 Artara Therapeutics